How does one predict and direct something that is by nature unpredictable and, by necessity, often undirected? According to David Guston, who is co-director of ASU?s Consortium for Science, Policy and Outcomes and a professor of political science, it is by strengthening society?s ability to nurture and guide innovation within socially acceptable frameworks.
A drug delivery system the size of a millionth of a centimeter could hold the key to more effective treatments of cancerous tumors. San Antonio researchers at the University of Texas Health Science Center and homegrown biotech firm Azaya Therapeutics Inc. have teamed up to test the new technology in humans and to bring it to the market.
On September 8, FDA is holding a public meeting to gather comments and data to assist the agency in the development of agency guidance that would clarify what information industry needs to provide FDA about nanoproducts, and also when the use of nanoscale materials may change the regulatory status of products..
The devices will be designed to adapt to physical changes in a patient's body and dissolve once they have healed, reducing the follow-up surgeries and potential complications of major orthopedic, craniofacial, and cardiovascular procedures and sparing millions of patients worldwide added pain and medical expenses.
Why is it that the origins of many serious diseases remain a mystery? In considering that question, a scientist at the University of California, San Diego School of Medicine has come up with a unified molecular view of the indivisible unit of life, the cell, which may provide an answer.
The project CDuR32 (Critical Dimensions and Registration for 32nm Mask Lithography) is funded in part by the German Federal Ministry of Education and Research. Of the total budget of ?16.7 million (about $24.3 million), the government contributes ?7.9.
Wie sicher ist Nano? Der Antwort wollen Wissenschaftler aus 29 Laendern beim Kongress Nanotox2008 vom 7. bis 10. September an der ETH Zuerich naeher kommen, der bislang groessten internationalen Tagung von Nanotoxikologen.
Just like works of art, wine is now being subjected to advanced testing to establish its authenticity: after measuring caesium 137 radioactivity levels to test the age of the wine, the glass in vintage wine bottles is now being tested by particle acceleration.
The NAD (Nanoparticles for therapy and diagnosis of Alzheimer's disease) Project is based on the use of nanoparticles for Alzheimer's diagnosis and therapy. The research, costing 14.6 million euros over 5 years, is financed by the European Union's 7th Framework Program and includes 19 European research centers.
The European Commission has published a number of calls for proposals under the specific programmes Cooperation and Capacities of the Seventh Framework Programme (FP7). One of them is a 'Biorefinery' joint call (two sections), including energy; environment (including climate change); food, agriculture and fisheries, and biotechnology; and nanosciences, nanotechnology, materials and new production technologies.
C. Erec Stebbins, associate professor at The Rockefeller University, has been awarded an inaugural EUREKA grant from the National Institutes of Health for a project aimed at exploiting a bacteria-based ?nanosyringe? as a means of delivering proteins into specific cells for therapeutic purposes.